Tech Company Financing Transactions

AviGenics Funding Round

AviGenics secured a $1.2 million funding round on 6/30/2008. Investors included Tullis Health Investors.

Transaction Overview

Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$1,156,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
111 Riverbend Rd.
Athens, GA 30605
USA
Email Address
Overview
AviGenics, Inc. is a bio-pharmaceutical company developing improved and cost-efficient bio-therapeutics for the treatment of cancer, infectious diseases, organ-dysfunction, genetic disorders and autoimmune diseases.
Profile
AviGenics LinkedIn Company Profile
Social Media
AviGenics Company Twitter Account
Company News
AviGenics News
Facebook
AviGenics on Facebook
YouTube
AviGenics on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2008: Provider HealthNet Services venture capital transaction
Next: 6/30/2008: Pivotal Systems venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary